231 related articles for article (PubMed ID: 9170200)
1. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis.
Kaplan MM
Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
Lee YM; Kaplan MM
Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
Kaplan MM; Cheng S; Price LL; Bonis PA
Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
5. Treatment of primary biliary cirrhosis.
Poupon R; Poupon RE
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):615-28. PubMed ID: 10976018
[TBL] [Abstract][Full Text] [Related]
6. Primary biliary cirrhosis.
Gong Y; Christensen E; Gluud C
N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
[No Abstract] [Full Text] [Related]
7. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate therapy for primary biliary cirrhosis.
Bach N; Bodian C; Bodenheimer H; Croen E; Berk PD; Thung SN; Lindor KD; Therneau T; Schaffner F
Am J Gastroenterol; 2003 Jan; 98(1):187-93. PubMed ID: 12526956
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
[TBL] [Abstract][Full Text] [Related]
10. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid.
Kaplan MM; Bonder A; Ruthazer R; Bonis PA
Dig Dis Sci; 2010 Nov; 55(11):3207-17. PubMed ID: 20559727
[TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis.
Kaplan MM; Gershwin ME
N Engl J Med; 2005 Sep; 353(12):1261-73. PubMed ID: 16177252
[No Abstract] [Full Text] [Related]
13. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of primary biliary cirrhosis].
Szalay F
Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
[No Abstract] [Full Text] [Related]
16. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
[TBL] [Abstract][Full Text] [Related]
17. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
[TBL] [Abstract][Full Text] [Related]
18. Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment.
Kaplan MM; DeLellis RA; Wolfe HJ
Ann Intern Med; 1997 May; 126(9):682-8. PubMed ID: 9139553
[TBL] [Abstract][Full Text] [Related]
19. [Primary biliary cirrhosis: therapeutic options].
Abenavoli L
Recenti Prog Med; 2009 Sep; 100(9):417-23. PubMed ID: 19886235
[TBL] [Abstract][Full Text] [Related]
20. [Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].
Raedsch R; Stiehl A; Walker S; Scherrmann JM; Kommerell B
Z Gastroenterol; 1992 Mar; 30 Suppl 1():55-7. PubMed ID: 1449019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]